Q&M Dental Group (Q&M)

Broker's Calls

DBS downgrades Q&M to 'hold', lowers TP to 53 cents on delayed expansion plans

On the back of Q&M's “disappointing” results, DBS has cut its earnings for the FY2022 and FY2023 by 31% and 33% respectively.

Results

Q&M sees 31% drop in earnings of $6.5 mil for 1QFY2022

The group has declared dividend of 0.4 cent per share for the period.

Digital Economy

OxPay appointed as digital payment for provider in Q&M Dental's clinics in Singapore

The rollout of the digital payment services programme will be done in two phases.

Broker's Calls

Q&M valuations still attractive despite 4QFY2021 earnings miss

CGS-CIMB and DBS have given Q&M "buy" calls with target prices of 79 cents and 72 cents respectively.

Results

Q&M Dental Group sees FY2021 earnings grow 55% to $30.5 mil on the back of a record FY2021 revenue of $205.6 mil

The group’s total dividend for FY2021 stood at 4 cents, translating to a yield of around 7% based on its last-closed share price.

Covid-19

Q&M's Acumen Diagnostics granted MOH Covid-19 offsite PCR testing license

PCR testing services will be rolled out to 10 clinics by Dec 31.
Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant - THE EDGE SINGAPORE

Covid-19

Q&M's Acumen Diagnostics says PCR test kits able to detect Omicron variant

This is in addition to being able to detect Covid-19 cases infected with the Delta variant, says the group.

SGX Research Series: 10 in 10

With no teething issues, Q&M eyes M&A for further growth

Get to know more about listed dental group, Q&M, here.
Analysts see Q&M subsidiary's acquisition of Acumen as positive; Maybank KE lifts TP to $1.03 - THE EDGE SINGAPORE

Broker's Calls

Analysts see Q&M subsidiary's acquisition of Acumen as positive; Maybank KE lifts TP to $1.03

To Maybank Kim Eng, the demand for testing should remain firm as Singapore prepares to live with Covid-19.
×